Company intelligence / Profile preview

Horizon Discovery

Cambridge (Waterbeach), Cambridgeshire, United Kingdom

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Horizon Discovery's tools (CRISPR, base editing, engineered cell lines) are industry-standard for advancing research, drug discovery, and diagnostics in over 2,000 customer organizations, including 19 of the 20 top pharma companies; no direct clinical outcomes reported as they are an enabling platform provider

Therapeutic areas: Rare Diseases
Modalities: CRISPR-based therapyBase editingRNA therapySmall molecule (as tools for screening and development)Gene modulationRecombinant protein (engineered cell lines for biologics)
Industry: Drug Discovery Services

Partnerships

19 of top 20 pharma companies are clientsAcademic research centers worldwideDiagnostics companies

Beyond the preview

Go deeper on Horizon Discovery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Horizon Discovery.

Explore the full profile